Results 121 to 130 of about 3,103 (173)
Some of the next articles are maybe not open access.
Formulary Drug Review: Cabotegravir
Hospital Pharmacy, 2021Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy and Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Terri L. Levien +2 more
openaire +1 more source
Current Opinion in HIV and AIDS, 2018
Analyzing the evidence for the strand transfer integrase inhibitor cabotegravir (CAB; GSK744, GSK1265744), its properties and differences from other compounds in the class, as well as reviewing the preclinical and clinical evidence for its potential in antretroviral therapy and medical HIV prevention.CAB has been investigated both as an oral and an ...
Hans-Jürgen, Stellbrink +1 more
openaire +2 more sources
Analyzing the evidence for the strand transfer integrase inhibitor cabotegravir (CAB; GSK744, GSK1265744), its properties and differences from other compounds in the class, as well as reviewing the preclinical and clinical evidence for its potential in antretroviral therapy and medical HIV prevention.CAB has been investigated both as an oral and an ...
Hans-Jürgen, Stellbrink +1 more
openaire +2 more sources